Patents by Inventor Zhanbin Zhang

Zhanbin Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12162904
    Abstract: A mannose derivative is an isonitrile-containing mannose derivative of formula (I), including different linking groups X: A radioactive preparation is provided, including a radiolabeled compound formed by radiolabeling the mannose derivative with a radionuclide. An application of the radioactive preparation in the diagnosis and treatment of tumors is also provided.
    Type: Grant
    Filed: November 17, 2023
    Date of Patent: December 10, 2024
    Assignee: Beijing Normal University
    Inventors: Junbo Zhang, Qing Ruan, Guangxing Yin, Xuebin Wang, Zhanbin Zhang, Zhigang Tang, Jie Lu
  • Publication number: 20240109929
    Abstract: A mannose derivative is an isonitrile-containing mannose derivative of formula (I), including different linking groups X: A radioactive preparation is provided, including a radiolabeled compound formed by radiolabeling the mannose derivative with a radionuclide. An application of the radioactive preparation in the diagnosis and treatment of tumors is also provided.
    Type: Application
    Filed: November 17, 2023
    Publication date: April 4, 2024
    Inventors: Junbo ZHANG, Qing RUAN, Guangxing YIN, Xuebin WANG, Zhanbin ZHANG, Zhigang TANG, Jie LU
  • Patent number: 11865194
    Abstract: Disclosed herein is a benzene ring-containing glucose derivative of formula (I): where R1 is each independently and R2 is hydrogen. This application also provides a radioactive drug, including a complex formed by the benzene ring-containing glucose derivative and a radionuclide. Use of the benzene ring-containing glucose derivative in the tumor treatment and diagnosis is further provided.
    Type: Grant
    Filed: April 7, 2023
    Date of Patent: January 9, 2024
    Assignee: Beijing Normal University
    Inventors: Junbo Zhang, Qianqian Gan, Qianna Wang, Xuran Zhang, Qing Ruan, Yuhao Jiang, Xuebin Wang, Zhigang Tang, Jie Lu, Zhanbin Zhang
  • Publication number: 20230263914
    Abstract: Disclosed herein is a benzene ring-containing glucose derivative of formula (I): , where R1 is each independently and R2 is hydrogen. This application also provides a radioactive drug, including a complex formed by the benzene ring-containing glucose derivative and a radionuclide. Use of the benzene ring-containing glucose derivative in the tumor treatment and diagnosis is further provided.
    Type: Application
    Filed: April 7, 2023
    Publication date: August 24, 2023
    Inventors: Junbo ZHANG, Qianqian GAN, Qianna WANG, Xuran ZHANG, Qing RUAN, Yuhao JIANG, Xuebin WANG, Zhigang TANG, Jie LU, Zhanbin ZHANG
  • Patent number: 11628228
    Abstract: A 99mTc-labeled isonitrile-containing glucose derivative having the general formula [99mTc-(CNDG)6]+, preparation method and use thereof is disclosed herein. The derivative is centered on 99mTc+, and the carbon atom of the isonitrile in CNDG coordinates with 99mTc(I) to form a hexacoordinated complex [99mTc-(CNDG)6]+. The [99mTc-(CNDG)6]+ derivative was obtained by the synthesis of the ligand CNDG and the preparation of the lyophilized CNDG kit. The derivative of this disclosure has good stability, simple preparation, high uptake and good retention at a tumor site, and high tumor/non-target ratio, and it is a novel 99mTc-labeled isonitrile-containing glucose derivative with excellent performance for tumor imaging. The derivative of this disclosure is advantageous for popularization and application.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: April 18, 2023
    Assignee: Beijing Shihong Pharmaceutical Research Center
    Inventors: Junbo Zhang, Xuran Zhang, Qianqian Gan, Xin Shao, Xuebin Wang, Zhigang Tang, Jie Lu, Zhanbin Zhang
  • Publication number: 20210220492
    Abstract: A 99mTc-labeled isonitrile-containing glucose derivative having the general formula [99mTc-(CNDG)6]+, preparation method and use thereof is disclosed herein. The derivative is centered on 99mTc+, and the carbon atom of the isonitrile in CNDG coordinates with 99mTc(I) to form a hexacoordinated complex [99mTc-(CNDG)6]+. The [99mTc-(CNDG)6]+ derivative was obtained by the synthesis of the ligand CNDG and the preparation of the lyophilized CNDG kit. The derivative of the present invention this disclosure has good stability, simple preparation, high uptake and good retention at a tumor site, and high tumor/non-target ratio, and it is a novel 99mTc-labeled isonitrile-containing glucose derivative with excellent performance for tumor imaging. The derivative of the present invention this disclosure is advantageous for popularization and application.
    Type: Application
    Filed: January 24, 2018
    Publication date: July 22, 2021
    Applicant: Beijing Shihong Pharmaceutical Research Center
    Inventors: Junbo Zhang, Xuran Zhang, Qianqian Gan, Xin Shao, Xuebin Wang, Zhigang Tang, Jie Lu, Zhanbin Zhang